Rl. Bai et al., INTERACTION OF DOLASTATIN-10 WITH TUBULIN - INDUCTION OF AGGREGATION AND BINDING AND DISSOCIATION REACTIONS, Molecular pharmacology, 47(5), 1995, pp. 965-976
We have prepared [H-3]dolastatin 10 and examined its interactions with
tubulin. Binding kinetics appeared to be biphasic, with a rapid initi
al reaction that could not be accurately measured, followed by a slowe
r second reaction. Bound drug was stable in centrifugal gel filtration
, column gel filtration, and high performance liquid chromatography ge
l filtration, but the bound drug could be displaced by an active isome
r of dolastatin 10. Scatchard analysis of binding data was consistent
with two classes of binding sites. However, dolastatin 10 induced an a
ggregation reaction upon binding to tubulin, complicating analysis of
the data, and incorporation of [H-3]dolastatin 10 into large aggregate
s was readily demonstrated. The chromatographic properties of the smal
lest radiolabeled species that could be documented were most consisten
t with a complex consisting of two molecules of alpha/beta-tubulin dim
er and two molecules of [H-3]dolastatin 10. The coexistence of an aggr
egation reaction with a binding reaction at a single site probably und
erlies the biphasic binding kinetics and the biphasic Scatchard plot.
Of peptides that strongly inhibit tubulin polymerization (dolastatin 1
0, dolastatin 10 isomers, segments, and analogs, dolastatin 15, and ph
omopsin A), only those previously shown to be strong inhibitors of vin
blastine binding and nucleotide exchange also strongly inhibited [3H]d
olastatin 10 binding and induced tubulin aggregation (dolastatin 10 it
self, two chiral isomers of dolastatin 10, and phomopsin A). The morph
ology of dolastatin 10-induced aggregates was compared with that of vi
nblastine-induced aggregates under a variety of reaction conditions. W
ith both drugs the aggregates had a more organized appearance when mic
rotubule-associated proteins were included in the reaction.